Here’s what you should know.
1. By selling those assets, Valeant saved interest on its debt repayment.
2. Valeant can cover its August 2018 bond when it matures.
3. When SeekingAlpha first reported on Valeant’s debt pathway, it seemed the bond would roll over with an additional 10 percent interest. Valeant will instead only pay the bond at 6.75 percent interest.
4. SeekingAlpha expects Valeant’s cash flow to increase.
More articles on gastroenterology/endoscopy:
Allergan expects solid 2017 under Trump administration; Takeda faces antirust suit & more —3 GI companies making waves
GI leader to know: Dr. Brij Dewan of Kalamazoo Gastroenterology
Pediatric irritable bowel syndrome patients often low in vitamin D: 4 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.